About Scott LaFee

Scott LaFee

Scott LaFee

Scott LaFee is a viviparous, omnivorous, longitudinally symmetrical carbon-based male biped and staff member of The San Diego Union-Tribune. Since 1992, he has been the chief writer for Quest, the paper's award-winning weekly science section, where he covers all manner of scientific news and features, from the inner workings of the brain to the physical nature of "nothingness" -- the stuff between stuff.

LaFee has written two syndicated columns for Creators. Archives of Eureka! can be found here. Or read Wellnews  - new releases weekly.  

He is married with two young sons, whom he coaches in soccer and swimming when not explaining why dead spiders' legs curl up (failed hydraulics) or how 8 feet of DNA can be squeezed into every cell (very carefully).

LaFee lives in La Mesa, Calif., with his hominid family and their several nonhuman pets: two tortoises, three fire-bellied toads, a rat, a rabbit and a dog named Dave.

...

Shouldering On Jun 17, 2026

The human shoulder is the most complex, mobile joint in the body, which makes it especially vulnerable to injury in people of all ages. Most often, injuries are related to aging as tendons become more vulnerable to repetitive or strenuous activity, l... Read More

...

Weight Up, Cognition Down Jun 10, 2026

Cognitive decline with age is a normal process. Our brains simply don't function as effectively as they did in our youth. But in otherwise normal healthy adults, the changes are gradual and subtle. The best way to slow cognitive decline is to adhere ... Read More

...

Release the Kratom Jun 03, 2026

Kratom is a tropical tree native to Southeast Asia whose leaves are used as the active ingredient in a host of compounds and supplements to self-treat conditions such as pain, coughing, diarrhea, anxiety and depression. In low doses, it acts as a sti... Read More

...

GLP-1 Drugs for Addiction? May 27, 2026

The long-term effects of using GLP-1 drugs like Ozempic and Wegovy for weight loss remain to be fully determined. Though GLP-1 drugs have been used for more than 20 years to treat diabetes, the first drug for weight loss was only approved in 2014, wi... Read More